Does a Proton Pump Inhibitor Cause Hypokalemia?-Reference-Cited by-同舟云学术

Does a Proton Pump Inhibitor Cause Hypokalemia?

Published:2011 Issue:9 Volume:50 Page:1045-1050
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Maeda Yoshitaka¹,Kojima Naoki²,Araki Yuya¹,Uno Tomomi¹,Nishigaki Keisuke¹,Inaba Naoto¹

Affiliation:

1. Division of Nephrology, Department of Internal Medicine, Toride Kyodo General Hospital (JA Toride Medical Center, renamed on April 1, 2011), Japan

2. Division of Gastroenterology, Department of Internal Medicine, Toride Kyodo General Hospital (JA Toride Medical Center, renamed on April 1, 2011), Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/50/9/50_9_1045/_pdf

Reference23 articles.

1. 1. Gumz ML, Lynch LJ, Greenlee MM, Cain BD, Wingo CS. The renal H⁺-K⁺ ATPases: physiology, regulation, and structure. Am J Physiol Renal Physiol 298: F12-F21, 2010.

2. 3. Howden CW, Reid JL. Omeprazole, a gastric 'proton pump inhibitor': lack of effect on renal handling of electrolytes and urinary acidification. Eur J Cllin Pharmacol 26: 639-640, 1984.

3. Uses of proton pump inhibitors and serum potassium levels

4. Role of potassium in acid secretion

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease;CASP J INTERN MED;2022

2. Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength;Journal of Basic and Clinical Physiology and Pharmacology;2021-10-25

3. Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors;International Urology and Nephrology;2020-02

4. Electrolyte disturbances in children receiving omeprazole for gastroesophageal reflux disease;Journal of Research in Medical Sciences;2020

5. Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis;Scientific Reports;2019-02-19